247 related articles for article (PubMed ID: 15336867)
1. Diagnosis and treatment of Candida vertebral osteomyelitis: clinical experience with a short course therapy of amphotericin B lipid complex.
Cone LA; Byrd RG; Potts BE; Wuesthoff M
Surg Neurol; 2004 Sep; 62(3):234-7; discussion 237. PubMed ID: 15336867
[TBL] [Abstract][Full Text] [Related]
2. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
Barcia JP
Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
[TBL] [Abstract][Full Text] [Related]
3. An unusual cause of vertebral osteomyelitis: Candida species.
Garbino J; Schnyder I; Lew D; Bouchuiguir-Wafa K; Rohner P
Scand J Infect Dis; 2003; 35(4):288-91. PubMed ID: 12839165
[TBL] [Abstract][Full Text] [Related]
4. Another patient with candida vertebral osteomyelitis treated with liposomal amphotericin B.
Cone LA; Dreisbach L; Dreisbach P; Wuesthoff M
Surg Neurol; 2005 Jun; 63(6):592. PubMed ID: 15936402
[No Abstract] [Full Text] [Related]
5. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
6. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
Virata SR; Kylstra JA; Brown JC; Wohl DA; Cohen MS
Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666
[No Abstract] [Full Text] [Related]
7. Treatment of Candida infections with amphotericin B lipid complex.
Ito JI; Hooshmand-Rad R
Clin Infect Dis; 2005 May; 40 Suppl 6():S384-91. PubMed ID: 15809924
[TBL] [Abstract][Full Text] [Related]
8. Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs.
Krawiec DR; McKiernan BC; Twardock AR; Swenson CE; Itkin RJ; Johnson LR; Kurowsky LK; Marks CA
J Am Vet Med Assoc; 1996 Dec; 209(12):2073-5. PubMed ID: 8960189
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with liposomal amphotericin B of an intraabdomianl abscess due to Candida norvegensis associated with a Gore-Tex mesh infection.
Nolla-Salas J; Torres-Rodríguez JM; Grau S; Isbert F; Torrella T; Riveiro M; Sitges-Serra A
Scand J Infect Dis; 2000; 32(5):560-2. PubMed ID: 11055666
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review.
Rowles DM; Fraser SL
Clin Infect Dis; 1999 Dec; 29(6):1564-5. PubMed ID: 10585814
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis.
Blowey DL; Garg UC; Kearns GL; Warady BA
Adv Perit Dial; 1998; 14():247-50. PubMed ID: 10649734
[TBL] [Abstract][Full Text] [Related]
12. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
13. Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex.
Knoppert DC; Salama HE; Lee DS
Ann Pharmacother; 2001 Sep; 35(9):1032-6. PubMed ID: 11573851
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
López-Vélez R; Videla S; Márquez M; Boix V; Jiménez-Mejías ME; Górgolas M; Arribas JR; Salas A; Laguna F; Sust M; Cañavate C; Alvar J;
J Antimicrob Chemother; 2004 Mar; 53(3):540-3. PubMed ID: 14739148
[TBL] [Abstract][Full Text] [Related]
15. Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
Drew R
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():36-44. PubMed ID: 16713192
[TBL] [Abstract][Full Text] [Related]
16. Ileal perforation and reactive hemophagocytic syndrome in a patient with disseminated histoplasmosis: the role of the real-time polymerase chain reaction in the diagnosis and successful treatment with amphotericin B lipid complex.
Guiot HM; Bertrán-Pasarell J; Tormos LM; González-Keelan C; Procop GW; Fradera J; Sánchez-Sergentón C; Méndez W
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):429-33. PubMed ID: 17141457
[TBL] [Abstract][Full Text] [Related]
17. Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
Turgut B; Vural O; Demir M; Kaldir M
Ann Hematol; 2002 Sep; 81(9):529-31. PubMed ID: 12373355
[TBL] [Abstract][Full Text] [Related]
18. Reversible dilated cardiomyopathy related to amphotericin B therapy.
Danaher PJ; Cao MK; Anstead GM; Dolan MJ; DeWitt CC
J Antimicrob Chemother; 2004 Jan; 53(1):115-7. PubMed ID: 14657095
[TBL] [Abstract][Full Text] [Related]
19. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia.
Cetin H; Yalaz M; Akisu M; Hilmioglu S; Metin D; Kultursay N
Pediatr Int; 2005 Dec; 47(6):676-80. PubMed ID: 16354223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
